Amani Makkouk

1.7k total citations
20 papers, 839 citations indexed

About

Amani Makkouk is a scholar working on Immunology, Oncology and Biomedical Engineering. According to data from OpenAlex, Amani Makkouk has authored 20 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 12 papers in Oncology and 6 papers in Biomedical Engineering. Recurrent topics in Amani Makkouk's work include Immunotherapy and Immune Responses (10 papers), CAR-T cell therapy research (8 papers) and Immune Cell Function and Interaction (8 papers). Amani Makkouk is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), CAR-T cell therapy research (8 papers) and Immune Cell Function and Interaction (8 papers). Amani Makkouk collaborates with scholars based in United States, Australia and Canada. Amani Makkouk's co-authors include George J. Weiner, Tatiana B. Krasieva, Henry Hirschberg, Seung‐Kuk Baek, Steen J. Madsen, Holbrook E. Kohrt, Cariad Chester, Alexander M. Abdelnoor, Chung-Ho Sun and Xue Yang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Amani Makkouk

19 papers receiving 822 citations

Peers

Amani Makkouk

IMMUN

ONCOL

BIOMA

James W. Opzoomer United Kingdom

May Tun Saung United States

Luan N. Nguyen Canada

Iraklis C. Kourtis Switzerland

Xiaoli Wei China

Sepideh Izadi Iran

Shozo Ohtsuki United States

Ashvin R. Jaiswal United States

Erik Berk United States

Surya Murty United States

James W. Opzoomer United Kingdom

Amani Makkouk

275 ×0.6

IMMUN

370 ×1.0

ONCOL

171 ×0.7

329 ×1.4

112 ×1.0

BIOMA

Citations per year, relative to Amani Makkouk Amani Makkouk (= 1×) peers James W. Opzoomer

Countries citing papers authored by Amani Makkouk

Since Specialization

Citations

This map shows the geographic impact of Amani Makkouk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amani Makkouk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amani Makkouk more than expected).

Fields of papers citing papers by Amani Makkouk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amani Makkouk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amani Makkouk. The network helps show where Amani Makkouk may publish in the future.

Co-authorship network of co-authors of Amani Makkouk

This figure shows the co-authorship network connecting the top 25 collaborators of Amani Makkouk. A scholar is included among the top collaborators of Amani Makkouk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amani Makkouk. Amani Makkouk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stone, Jennifer D., Kamonwan Fish, Devika Ashok, et al.. (2024). Abstract ND01: ABBV-303: A novel NK and CD8 T cell engager specific for c-Met-expressing tumors. Cancer Research. 84(7_Supplement). ND01–ND01. 1 indexed citations

Makkouk, Amani, et al.. (2021). Re-Evaluating the Effects of Obesity on Cancer Immunotherapy Outcomes in Renal Cancer: What Do We Really Know?. Frontiers in Immunology. 12. 668494–668494. 16 indexed citations

Makkouk, Amani, Xue Yang, Anthony Lucas, et al.. (2021). Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 9(12). e003441–e003441. 134 indexed citations

Makkouk, Amani, Xue Yang, Anthony Lucas, et al.. (2021). Allogeneic Vδ1 gamma delta T cells engineered with glypican-3 (GPC3)-specific CAR expressing soluble IL-15 have enhanced antitumor efficacy against hepatocellular carcinoma in preclinical models.. Journal of Clinical Oncology. 39(15_suppl). e14511–e14511. 3 indexed citations

Makkouk, Amani, Xue Yang, Anthony Lucas, et al.. (2021). 119 ADI-002: an IL-15 armored allogeneic ‘off-the-shelf’ Vδ1 gamma delta CAR T cell therapy for solid tumors targeting glypican-3 (GPC3). Regular and Young Investigator Award Abstracts. A128–A128. 3 indexed citations

Emberley, Ethan, Mark K. Bennett, Matthew Gross, et al.. (2018). Abstract 3509: The glutaminase inhibitor CB-839 synergizes with CDK4/6 and PARP inhibitors in pre-clinical tumor models. Cancer Research. 78(13_Supplement). 3509–3509. 12 indexed citations

Makkouk, Amani, Vandana Sundaram, C. Susan Chester, et al.. (2016). Characterizing CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy. Annals of Oncology. 28(2). 415–420. 14 indexed citations

Souza-Fonseca-Guimarães, Fernando, Stephen J. Blake, Amani Makkouk, et al.. (2016). Anti-CD137 enhances anti-CD20 therapy of systemic B-cell lymphoma with altered immune homeostasis but negligible toxicity. OncoImmunology. 5(7). e1192740–e1192740. 10 indexed citations

Makkouk, Amani, Cariad Chester, & Holbrook E. Kohrt. (2016). Rationale for anti-CD137 cancer immunotherapy. European Journal of Cancer. 54. 112–119. 65 indexed citations

10.

Steggerda, Susanne, Mark K. Bennett, Jason Chen, et al.. (2016). Abstract B045: Arginase inhibitor CB-1158 elicits immune-mediated antitumor responses as a single agent and in combination with other immunotherapies. Cancer Immunology Research. 4(11_Supplement). B045–B045. 2 indexed citations

11.

Steggerda, Susanne, Ethan Emberley, Matthew Gross, et al.. (2016). Arginase inhibitor CB-1158 elicits immune-mediated anti-tumor responses as a single agent and enhances the efficacy of other immunotherapies. European Journal of Cancer. 69. S97–S97. 3 indexed citations

12.

Makkouk, Amani, Vijaya B. Joshi, Caitlin D. Lemke, et al.. (2015). Three Steps to Breaking Immune Tolerance to Lymphoma: A Microparticle Approach. Cancer Immunology Research. 3(4). 389–398. 11 indexed citations

13.

Makkouk, Amani, Vandana Sundaram, Manisha Desai, et al.. (2015). Predicting CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy. Journal for ImmunoTherapy of Cancer. 3(Suppl 2). P98–P98. 1 indexed citations

14.

Makkouk, Amani, Vijaya B. Joshi, Amaraporn Wongrakpanich, et al.. (2014). Biodegradable Microparticles Loaded with Doxorubicin and CpG ODN for In Situ Immunization Against Cancer. The AAPS Journal. 17(1). 184–193. 48 indexed citations

15.

Makkouk, Amani, Vijaya B. Joshi, Caitlin D. Lemke, et al.. (2014). Three Steps to Breaking Immune Tolerance: A Microparticle Approach. Blood. 124(21). 4504–4504. 1 indexed citations

16.

Makkouk, Amani & George J. Weiner. (2014). Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge. Cancer Research. 75(1). 5–10. 240 indexed citations

17.

Baek, Seung‐Kuk, Amani Makkouk, Tatiana B. Krasieva, et al.. (2011). Photothermal treatment of glioma; an in vitro study of macrophage-mediated delivery of gold nanoshells. Journal of Neuro-Oncology. 104(2). 439–448. 130 indexed citations

18.

Madsen, Steen J., Seung‐Kuk Baek, Amani Makkouk, Tatiana B. Krasieva, & Henry Hirschberg. (2011). Macrophages as Cell-Based Delivery Systems for Nanoshells in Photothermal Therapy. Annals of Biomedical Engineering. 40(2). 507–515. 100 indexed citations

19.

Makkouk, Amani, Henry Hirschberg, H. Michael Gach, & Steen J. Madsen. (2010). Near-infrared-activated gold nanoshells for thermal ablation of macrophages in vitro. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 7548. 754840–754840.

20.

Makkouk, Amani & Alexander M. Abdelnoor. (2009). The potential use of toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents. Immunopharmacology and Immunotoxicology. 31(3). 331–338. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact